Skip to main content
Clinical Trials/ISRCTN16968002
ISRCTN16968002
Active, not recruiting
未知

The effects of thoracic manipulation for impaired lower extremity neural dynamics

Franklin Pierce University0 sites30 target enrollmentSeptember 26, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Treatment of neural tension in the lower extremities in participants with radiating leg pain.
Sponsor
Franklin Pierce University
Enrollment
30
Primary Endpoint
Lower extremity neural tension range of motion is measured using a goniometer with the following standardized tests at baseline, immediately after the intervention, and 30 minutes post-intervention:1. Knee extension range of motion with the slump test2. Hip flexion range of motion with the passive straight leg raise test
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2024
End Date
June 18, 2027
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged between 18-60 years old recruited from the community

Exclusion Criteria

  • Ehler's Danlos and Marfan's Disease
  • The inability to provide verbal consent
  • Severe pain
  • Bone disease
  • Unhealed fractures or spinal fractures
  • Current infections
  • A history of deep vein thrombosis
  • Current pregnancy

Outcomes

Primary Outcomes

Lower extremity neural tension range of motion is measured using a goniometer with the following standardized tests at baseline, immediately after the intervention, and 30 minutes post-intervention:1. Knee extension range of motion with the slump test2. Hip flexion range of motion with the passive straight leg raise test

Secondary Outcomes

  • 1. Pain measured using a Visual Analog Scale (VAS) at baseline, immediately after the intervention, and 30 minutes post-intervention2. Level of disability measured using the Oswestry Disability Index at baseline to categorize participants on the level of severity of their condition3. Risk classification measured using Keele STarT at baseline to categorize patients on the level of severity of their condition

Similar Trials